David Kaplan

Dr. David Kaplan graduated with A.B, Ph.D., and M.D. degrees from the University of Chicago.  He was a pathology resident at Barnes and Jewish Hospitals and a postdoctoral fellow at Washington University.  Since 1984 he served as a faculty member at Case Western Reserve University and an attending physician at University Hospitals Cleveland.  In 2016 he founded a biotechnology company based on his invention of a powerful technology that enhanced the sensitivity of flow cytometric analysis.  Dr. Kaplan has made many advancements throughout his scientific career including the first cloning of human influenza-specific cytotoxic T cells, the first gene transfer into human T cells, the first use of antisense transfection to inhibit expression of a protein to probe its function in the context of the human T cell, and the first demonstration of intercellular immunoregulation via cell surface receptors.